Hbk Sorce Advisory LLC Moderna, Inc. Transaction History

Hbk Sorce Advisory LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $122,094 - $177,318	-900 Reduced 45.05%	1,098 $314,000
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $236,523 - $419,659	1,998 New	1,998 $359,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $139,033 - $209,612	-1,187 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $94,465 - $175,582	-747 Reduced 38.62%	1,187 $204,000
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $70,681 - $115,343	313 Added 19.31%	1,934 $491,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $21,746 - $47,478	-98 Reduced 5.7%	1,621 $624,000
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $1,558 - $2,819	12 Added 0.7%	1,719 $404,000
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $186,370 - $317,467	1,707 New	1,707 $224,000
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $509,090 - $1.32 Million	-7,744 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $190,733 - $332,923	-3,510 Reduced 31.19%	7,744 $548,000
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $333,906 - $900,320	11,254 New	11,254 $723,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.